{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-093304","form_type":"8-K","ticker":"AMLX","cik":"0001658551","company_name":"Amylyx Pharmaceuticals, Inc.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.002984+00:00","generated_at":"2026-05-31T10:58:52.107065+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Amylyx Q2 net loss $72.7M; revenue negative after RELYVRIO withdrawal; avexitide acquisition","bullets":["Q2 net loss $72.7M ($1.07/share) vs net income $22.1M ($0.31) a year ago; revenue negative $(1.0)M after RELYVRIO/ALBRIOZA withdrawal.","Cash $309.8M at June 30, down from $373.3M at March 31; runway into 2026.","Acquired avexitide (GLP-1 antagonist) with FDA Breakthrough Therapy; PBH Phase 3 plan Q1 2025.","Restructuring $22.9M largely severance; headcount reduced after PHOENIX failure and product discontinuation.","R&D down to $23.3M, SG&A to $21.6M; cost cuts and pipeline shift from RELYVRIO."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-093304","json":"https://secwatch.observer/filing/0000950170-24-093304.json","markdown":"https://secwatch.observer/filing/0000950170-24-093304.md","text":"https://secwatch.observer/filing/0000950170-24-093304.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658551/000095017024093304/0000950170-24-093304-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658551/000095017024093304/amlx-20240808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:58:52.107065+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}